Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Understanding and Preventing the Rise of Cancer in 20- to 40-Year-Olds: A Challenge for an Entire Generation
The number of cancers diagnosed in people under 50 is increasing worldwide, affecting a growing number of young adults in the midst of their working lives. In response to this worrying trend, researchers and clinicians are collaborating to understand the causes, enhance prevention, and refine screening strategies. The aim: to turn this health alert into a driver of action and hope for generations to come.
Published on
The number of cancers diagnosed in people under 50 is increasing worldwide, affecting a growing number of young adults in the midst of their working lives. In response to this worrying trend, researchers and clinicians are collaborating to understand the causes, enhance prevention, and refine screening strategies. The aim: to turn this health alert into a driver of action and hope for generations to come.
Once regarded as a disease of old age, cancer is now increasingly affecting young adults, with the incidence of these early-onset tumours rising globally, according to an article published on 3 September 2025 in ESMO Open and co-authored by physician-researchers at Gustave Roussy.
20- to 40-Year-Olds on the Front Line
Long considered a low-risk age group, 20- to 40-year-olds are being diagnosed with cancer more and more often. Biologically, young adults are in a unique life stage: they have completed puberty but have not yet experienced the effects of ageing (reduced hormone production, weakening of the immune system, onset of chronic diseases). These patients are often in the process of building their professional, family and social lives. Diagnosis is frequently delayed: young adults, believing themselves to be healthy, tend to downplay their symptoms, and screening programmes—apart from cervical screening—rarely target those under 40.
In 2022, there were more than 1.2 million new cases and 350,000 deaths worldwide among this age group. These cancers often affect the digestive system (colorectal, stomach, liver, pancreas), as well as the breast, thyroid, kidneys, testicles, and even, in some cases, the lungs of young non-smokers.
The trend is particularly pronounced among women, whose incidence rates now exceed those of men of the same age, largely due to breast and thyroid cancers. By 2050, projections indicate a 13% increase in both cases and deaths linked to early-onset cancers.
The exact causes of this rise remain to be clarified. Researchers suggest several possible contributing factors: increasing rates of obesity, pollution, endocrine disruptors, diet, sedentary lifestyles, and early exposure to certain treatments and environmental agents.
To address this significant global public health challenge, Gustave Roussy has launched the POWER for YA programme, a dedicated research initiative focused on cancers in individuals aged 20 to 40. Its goal is to intensify research, rethink prevention, and raise awareness among younger generations.
Source
F. André, E. Rassy, B. Achutti-Duso, A. Boilève, C. Smolenschi, S. Delaloge, F. Barlesi,
The rising tides of cancers among young adults
ESMO Open, Volume 10, Issue 9, 2025, 105553, ISSN 2059-7029,
https://doi.org/10.1016/j.esmoop.2025.105553
https://www.sciencedirect.com/science/article/pii/S205970292501422X
Last news
-
Breast Cancer: Gustave Roussy Ranked No. 1 in France for Breast Surgery and Breast Reconstruction
On the occasion of Breast Cancer Awareness Month, the 2025 data from Visuchir, the national surgical activity monitoring tool of the French Health Insurance system, places Gustave Roussy in first position for both breast surgery and breast reconstruction. Beyond this ranking, these figures highlight that reconstruction is now an integral part of breast cancer treatment. It is considered at every stage of care: from tumor removal surgery, whether lumpectomy or mastectomy, through to the post-cancer period, helping to restore the body and support women in regaining their physical integrity and quality of life.
-
Newsweek Ranking: Gustave Roussy Named Europe’s Leading Cancer Centre and Third Best Worldwide
The 2027 edition of Newsweek’s World's Best Specialized Hospitals ranking once again recognises Gustave Roussy as the leading cancer centre in France and Europe, and the third best worldwide. This distinction highlights the excellence of the Institute’s care and research, as well as the daily commitment of all its professionals.
-
Living with and beyond cancer: the promises and challenges of digital health
In a Viewpoint article published in The Lancet Digital Health, Drs Ines Vaz-Luis and Maria Alice Franzoi, together with Emmanuel Mussault, a patient partner at the PRISM University Hospital Institute, examine the role that digital tools can play in supporting people living with and beyond cancer. Their central message is that these technologies can support more personalised and accessible care, but their value depends primarily on how they are integrated into care pathways, the human support provided, their ability to address individual needs and their evaluation in real-world settings.
-
Gustave Roussy and The Lancet launch an international lecture series on innovations transforming cancer care
The inaugural lecture in the “Lecture Series on Cancer Breakthroughs” will take place on Friday 18 September at 5:00 pm. It will be delivered by Professor Timothy R. Rebbeck, a leading cancer prevention specialist at Harvard University and the Dana-Farber Cancer Institute.
